StockTipsArenaBeta
This is a duplicate capture of an earlier tip — the same call recorded from another source.View original

BUY Aurobindo Pharma — HSBC Securities

BUYAurobindo Pharma

byHSBC SecuritiesHorizon: NA (inferred 1 year)1 Sept 2026via CNBC Awaaz.

Entry₹1,700Inferred
Target₹1,900
Total upside +11.76%
Stop lossNot given
CMP₹1,653.12d ago
N/A (Duplicate)-2.76%+14.94%upside left 12 mo left
Follow HSBC Securities for new calls(100% target hit, 10 closed calls)Get alertsWatch AUROPHARMA for new buy/sell callsGet alertsSee 10 active Long-term calls on AUROPHARMASee 177 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.